{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-242031","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2022-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.980030+00:00","generated_at":"2026-06-23T11:54:15.984105+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Coherus appoints Bryan McMichael as Principal Accounting Officer","bullets":["McMichael, age 44, appointed PAO effective Sept 7, 2022; had been SVP, Accounting and Corporate Controller since March 2021.","Receives stock option award of 15,000 shares vesting monthly over four years.","Succeeds McDavid Stilwell, who remains CFO and Principal Financial Officer; transition is planned with no disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-242031","json":"https://secwatch.observer/filing/0001193125-22-242031.json","markdown":"https://secwatch.observer/filing/0001193125-22-242031.md","text":"https://secwatch.observer/filing/0001193125-22-242031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/0001193125-22-242031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/d385883d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:54:15.984105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"490384135c","claim":"Bryan McMichael was appointed as Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer at Coherus Oncology, Inc..","evidence_excerpt":"On September 9, 2022, Coherus BioSciences, Inc. (the “Company”) announced the appointment of Bryan McMichael, age 44, as Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer, effective September 7, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/0001193125-22-242031-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"aef962b965","claim":"McDavid Stilwell changed role as Principal Accounting Officer at Coherus Oncology, Inc..","evidence_excerpt":"Mr. Stilwell continues his service to the Company as the Company’s Chief Financial Officer and Principal Financial Officer but will no longer serve as Principal Accounting Officer effective September 7, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/0001193125-22-242031-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}